Cargando…

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages

Detalles Bibliográficos
Autores principales: Arora, Prerna, Zhang, Lu, Nehlmeier, Inga, Kempf, Amy, Cossmann, Anne, Dopfer-Jablonka, Alexandra, Schulz, Sebastian R, Jäck, Hans-Martin, Behrens, Georg M N, Pöhlmann, Stefan, Hoffmann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621698/
https://www.ncbi.nlm.nih.gov/pubmed/36327999
http://dx.doi.org/10.1016/S1473-3099(22)00693-4
_version_ 1784821603209576448
author Arora, Prerna
Zhang, Lu
Nehlmeier, Inga
Kempf, Amy
Cossmann, Anne
Dopfer-Jablonka, Alexandra
Schulz, Sebastian R
Jäck, Hans-Martin
Behrens, Georg M N
Pöhlmann, Stefan
Hoffmann, Markus
author_facet Arora, Prerna
Zhang, Lu
Nehlmeier, Inga
Kempf, Amy
Cossmann, Anne
Dopfer-Jablonka, Alexandra
Schulz, Sebastian R
Jäck, Hans-Martin
Behrens, Georg M N
Pöhlmann, Stefan
Hoffmann, Markus
author_sort Arora, Prerna
collection PubMed
description
format Online
Article
Text
id pubmed-9621698
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-96216982022-11-01 The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages Arora, Prerna Zhang, Lu Nehlmeier, Inga Kempf, Amy Cossmann, Anne Dopfer-Jablonka, Alexandra Schulz, Sebastian R Jäck, Hans-Martin Behrens, Georg M N Pöhlmann, Stefan Hoffmann, Markus Lancet Infect Dis Correspondence Elsevier Ltd. 2022-12 2022-10-31 /pmc/articles/PMC9621698/ /pubmed/36327999 http://dx.doi.org/10.1016/S1473-3099(22)00693-4 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Arora, Prerna
Zhang, Lu
Nehlmeier, Inga
Kempf, Amy
Cossmann, Anne
Dopfer-Jablonka, Alexandra
Schulz, Sebastian R
Jäck, Hans-Martin
Behrens, Georg M N
Pöhlmann, Stefan
Hoffmann, Markus
The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
title The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
title_full The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
title_fullStr The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
title_full_unstemmed The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
title_short The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
title_sort effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging sars-cov-2 ba.4 and ba.5 sublineages
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621698/
https://www.ncbi.nlm.nih.gov/pubmed/36327999
http://dx.doi.org/10.1016/S1473-3099(22)00693-4
work_keys_str_mv AT aroraprerna theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT zhanglu theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT nehlmeieringa theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT kempfamy theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT cossmannanne theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT dopferjablonkaalexandra theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT schulzsebastianr theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT jackhansmartin theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT behrensgeorgmn theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT pohlmannstefan theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT hoffmannmarkus theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT aroraprerna effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT zhanglu effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT nehlmeieringa effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT kempfamy effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT cossmannanne effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT dopferjablonkaalexandra effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT schulzsebastianr effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT jackhansmartin effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT behrensgeorgmn effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT pohlmannstefan effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages
AT hoffmannmarkus effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages